PET/CT scan to study infection in adults with S. aureus in blood
Part of Infections clinical trials.
This study uses a special whole-body scan (PET/CT) to learn more about how a Staphylococcus aureus bloodstream infection behaves in the body. It may help doctors better understand infection severity and guide care for people with this diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- A lab test has grown Staphylococcus aureus (a specific group of this germ) from at least one blood culture.
- You have symptoms that fit a Staphylococcus aureus bloodstream infection.
- You are admitted to a hospital taking part in the study when you are screened, and you agree to have a PET/CT scan.
- Your care team believes the study is in your best interest.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests the best treatment approach for bloodstream infections caused by Staphylococcus aureus (“S. aureus”). It uses a flexible design to decide which treatment track you fit into, and may help improve recovery while avoiding unnecessary medications.
This study looks at different types of Staph aureus blood infections to understand which ones are more likely to cause severe illness or death. It may help doctors predict who needs more aggressive treatment.
This study looks at how severe infections like sepsis can hurt the kidneys. By using special scans (PET-CT), researchers hope to better understand why this happens, which could lead to better treatments.
This trial tests whether using a blood test called 'PCT' can help doctors decide when to start or stop antibiotics in critically ill adult patients in the EICU. The goal is to reduce unnecessary antibiotic use while still effectively treating bacterial infections.
This study tests different combinations of antibiotics to treat a staph infection in the blood. If you're in an Intermountain hospital with this infection, the trial may help doctors find the most effective treatment for you.
This study tests a new blood test (Microbio InfectID-BSI) to see how well it detects bacteria and yeast in patients with a possible bloodstream infection. If you are already having a blood culture done, the study will collect extra blood samples at the same time to compare the new test's results.
Hear when a new Staphylococcus Aureus Bacteremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.